NO942660L - Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier - Google Patents
Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadierInfo
- Publication number
- NO942660L NO942660L NO942660A NO942660A NO942660L NO 942660 L NO942660 L NO 942660L NO 942660 A NO942660 A NO 942660A NO 942660 A NO942660 A NO 942660A NO 942660 L NO942660 L NO 942660L
- Authority
- NO
- Norway
- Prior art keywords
- cells
- cytolytic
- precursors
- pbmcs
- characteristic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82393392A | 1992-01-21 | 1992-01-21 | |
| PCT/US1993/000083 WO1993014189A1 (en) | 1992-01-21 | 1993-01-07 | Method for determining cytolytic t cell precursors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO942660D0 NO942660D0 (no) | 1994-07-15 |
| NO942660L true NO942660L (no) | 1994-09-16 |
Family
ID=25240169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO942660A NO942660L (no) | 1992-01-21 | 1994-07-15 | Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0624189A4 (ja) |
| JP (1) | JPH07503134A (ja) |
| KR (1) | KR950700402A (ja) |
| AU (1) | AU3435293A (ja) |
| CA (1) | CA2128424A1 (ja) |
| FI (1) | FI943422A0 (ja) |
| NO (1) | NO942660L (ja) |
| WO (1) | WO1993014189A1 (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU664560B2 (en) * | 1991-05-23 | 1995-11-23 | Ludwig Institute For Cancer Research | Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| US6280962B1 (en) | 1991-11-25 | 2001-08-28 | Yoreh Biotechnologies Ltd. | Whole blood/mitogen assay for the early detection of a subject with cancer and kit |
| US6352826B1 (en) | 1991-11-25 | 2002-03-05 | Yoreh Biotechnologies, Ltd. | Method and kit for the detection of retroviral specific antibodies in seronegative individuals |
| US6322989B1 (en) | 1991-11-25 | 2001-11-27 | Yoreh Biotechnologies, Ltd. | Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit |
| EP0756604A1 (en) | 1994-04-22 | 1997-02-05 | THE UNITED STATES OF AMERICA, as represented by the Secretary of the Department of Health and Human Services | Melanoma antigens |
| US5874560A (en) | 1994-04-22 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Melanoma antigens and their use in diagnostic and therapeutic methods |
| US5843648A (en) * | 1995-01-10 | 1998-12-01 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
| US7501501B2 (en) | 1995-09-26 | 2009-03-10 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | MHC-Class II restricted melanoma antigens and their use in therapeutic methods |
| US6951917B1 (en) | 1995-09-26 | 2005-10-04 | The United States Of America As Represented By The Department Of Health And Human Services | MHC-class II restricted melanoma antigens and their use in therapeutic methods |
| CA2243235C (en) * | 1996-01-17 | 2010-08-10 | Imperial College Innovations Limited | Immunotherapy using cytotoxic t lymphocytes (ctl) |
| US20040156861A1 (en) | 1996-07-11 | 2004-08-12 | Figdor Carl Gustav | Melanoma associated peptide analogues and vaccines against melanoma |
| JP2001504233A (ja) * | 1996-11-22 | 2001-03-27 | シルーヴ メディカル テクノロジーズ リミテッド | 癌を有する被験者の早期検出のための全血/マイトジェンアッセイおよびキット |
-
1993
- 1993-01-07 JP JP5512545A patent/JPH07503134A/ja active Pending
- 1993-01-07 EP EP93902961A patent/EP0624189A4/en not_active Withdrawn
- 1993-01-07 FI FI943422A patent/FI943422A0/fi not_active Application Discontinuation
- 1993-01-07 WO PCT/US1993/000083 patent/WO1993014189A1/en not_active Ceased
- 1993-01-07 CA CA002128424A patent/CA2128424A1/en not_active Abandoned
- 1993-01-07 KR KR1019940702508A patent/KR950700402A/ko not_active Withdrawn
- 1993-01-07 AU AU34352/93A patent/AU3435293A/en not_active Abandoned
-
1994
- 1994-07-15 NO NO942660A patent/NO942660L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0624189A1 (en) | 1994-11-17 |
| KR950700402A (ko) | 1995-01-16 |
| NO942660D0 (no) | 1994-07-15 |
| CA2128424A1 (en) | 1993-07-22 |
| EP0624189A4 (en) | 1995-05-17 |
| FI943422A7 (fi) | 1994-07-19 |
| FI943422L (fi) | 1994-07-19 |
| AU3435293A (en) | 1993-08-03 |
| WO1993014189A1 (en) | 1993-07-22 |
| JPH07503134A (ja) | 1995-04-06 |
| FI943422A0 (fi) | 1994-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO861104L (no) | Fremgangsmaate for bestemmelse av monomersekvensen i molekyler. | |
| NO942660L (no) | Fremgangsmåte til bestemmelse av cytolytiske T-celle-forstadier | |
| DK122184D0 (da) | Indretning til mikrobiologisk afproevning | |
| DK393886A (da) | Monoklone antistoffer og antigen for humane ikke-smaacellede lungecarcinomer | |
| ES511797A0 (es) | "metodo para ensayar reacciones antigeno-anticuerpo". | |
| EP0140379A3 (en) | Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies | |
| EP0247730A3 (en) | Antibodies, their preparation and use and products containing them | |
| NO932320D0 (no) | Fremgangsmaate for paavisning av en analytt i en proeve og et utstyrsett for denne | |
| DK98187A (da) | Monoklonale antistoffer og antigen for human ikke-smaacellet lungecarcinoma og visse andre typer human carcinoma | |
| DK199779A (da) | Renset antigen til undersoegelse for neisseria gonorrhoeae antistoffer | |
| DE2965570D1 (en) | Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination | |
| AU1971295A (en) | Humanized monoclonal antibodies against human interleukin-4 | |
| DK344579A (da) | Diagnostisk middel og fremgangsmaade til paavisning af antimitochondriale eller antinukleaere antistoffer | |
| NO172910C (no) | Fremgangsmaate for utproeving av en proeve av celler med hensyn til naervaer av celleoverflateantigen | |
| DK247486D0 (da) | Nonoklone antistoffer og deres anvendelse | |
| ES8606948A1 (es) | Mejoras intruducidas en un ensayo para determinar un antigeno bacteriano en una muestra de ensayo | |
| DK412184A (da) | Molekylaert klonet diagnostisk produkt og fremgangsmaade til in vitro detektion af antistof eller antigen | |
| ATE135468T1 (de) | Vorprüfung von prostatakrebs durch serum prostatischen spezifischen antigen | |
| NO880835L (no) | Fremgangsmaate og anordning for kvalitativ og/eller kvantitativ analyse av antigener, antistoffer, mikroorganismer eller andre celler. | |
| ES2187639T3 (es) | Analisis de fijacion competitiva para antigenos plaquetarios. | |
| EP0248147A3 (en) | Method of determining the presence of cancer cells | |
| DK0824696T3 (da) | Fremgangsmåde og kit til at forudsige den terapeutiske reaktion på et medikament mod en malign tumor | |
| DK98692A (da) | Monoklonalt antistof og fremgangsmaade til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og proeve for tumorcellefoelsomhed under anvendelse af det monoklonale antistof | |
| AU538833B2 (en) | Method of diagnosing arterosclerosis | |
| JPS56150356A (en) | Immunologic measuring method |